Vir Biotechnology, Inc. VIR Business Segments — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s business segments — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s business segments — total revenues?
- Vir Biotechnology, Inc. (VIR) reported business segments — total revenues of -$29K in Q1 2026.
- How has Vir Biotechnology, Inc.'s business segments — total revenues changed year-over-year?
- Vir Biotechnology, Inc.'s business segments — total revenues decreased by 101.0% year-over-year, from $3.03M to -$29K.
- What is the long-term trend for Vir Biotechnology, Inc.'s business segments — total revenues?
- Over 2 years (2022 to 2025), Vir Biotechnology, Inc.'s business segments — total revenues has grown at a -79.4% compound annual growth rate (CAGR), from $1.62B to $68.56M.
- What does business segments — total revenues mean?
- Represents the total gross income generated by the primary business segment through its core operations, including product sales, royalties, and collaboration revenue. This metric serves as a key indicator of the segment's market traction and its ability to monetize its technology platforms.